Author Affiliations1Institute of Clinical and Experimental Lymphology of SB RAMS, 630117, Novosibirsk, Timakov str., 2; Institute of Circulation Pathology n.a. E.N. Meshalkin of Minzdrav of Russia, 630055, Novosibirsk, Rechkunovskaya str., 15
2Institute of Clinical and Experimental Lymphology of SB RAMS, 630117, Novosibirsk, Timakov str., 2; Institute of Circulation Pathology n.a. E.N. Meshalkin of Minzdrav of Russia, 630055, Novosibirsk, Rechkunovskaya str., 15
3Institute of Clinical and Experimental Lymphology of SB RAMS, 630117, Novosibirsk, Timakov str., 2; Institute of Circulation Pathology n.a. E.N. Meshalkin of Minzdrav of Russia, 630055, Novosibirsk, Rechkunovskaya str., 15
4Institute of Circulation Pathology n.a. E.N. Meshalkin of Minzdrav of Russia, 630055, Novosibirsk, Rechkunovskaya str., 15
5Institute of Circulation Pathology n.a. E.N. Meshalkin of Minzdrav of Russia, 630055, Novosibirsk, Rechkunovskaya str., 15
6Institute of Clinical and Experimental Lymphology of SB RAMS, 630117, Novosibirsk, Timakov str., 2; Institute of Circulation Pathology n.a. E.N. Meshalkin of Minzdrav of Russia, 630055, Novosibirsk, Rechkunovskaya str., 15
7Institute of Clinical and Experimental Lymphology of SB RAMS, 630117, Novosibirsk, Timakov str., 2; Institute of Circulation Pathology n.a. E.N. Meshalkin of Minzdrav of Russia, 630055, Novosibirsk, Rechkunovskaya str., 15
8Institute of Clinical and Experimental Lymphology of SB RAMS, 630117, Novosibirsk, Timakov str., 2; Institute of Circulation Pathology n.a. E.N. Meshalkin of Minzdrav of Russia, 630055, Novosibirsk, Rechkunovskaya str., 15
9Institute of Circulation Pathology n.a. E.N. Meshalkin of Minzdrav of Russia, 630055, Novosibirsk, Rechkunovskaya str., 15
10Institute of Clinical and Experimental Lymphology of SB RAMS, 630117, Novosibirsk, Timakov str., 2; Institute of Circulation Pathology n.a. E.N. Meshalkin of Minzdrav of Russia, 630055, Novosibirsk, Rechkunovskaya str., 15
1. Konenkov V.I., Poveshchenko O.V., Kim I.I. et al. Effect on G-CSF on proangiogenic properties mobilized peripheral blood cells in patients with chronic heart failure // Кletochnaya transplantologiya i tkanevaya inzheneriya. 2011. (3). 71–76. (in Russian)
2. Poveshchenko O.V, Poveshchenko A.F, Konenkov V.I. Physiological and cytological basis of cellular regulation of angiogenesis // Uspekhi fiziologicheskikh nauk. 2012. (3). 48–61. (in Russian)
3. Popov S.V., Ryabov V.V., Suslova T.E. et al. Fundamental and applied aspects of cell technologies in cardiology and cardiac surgery // Byulleten' Sibirskogo otdeleniya Rossiyskoy akademii meditsinskikh nauk. 2008. (4). 5–15. (in Russian)
4. Anderlini P., Champlin R.E. Biologic and molecular effects of granulocyte colony– stimulating factor in healthy individuals: recent findings and current challenges // Blood. 2008. (111). 1767–1772.
5. Falcão Mda C., Zírpoli J.C., Albuquerque V.M. et al. Association of biomarkers with atherosclerosis and risk for coronary artery disease in patients with HIV // Arq. Bras. Cardiol. 2012. 99. (5). 971–978.
6. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy // Circ. Res. 2008. (103). 1204–1219.
7. Gullestad L., Kjekshus J., Damas J.K. et al. Agents targeting inflammation in heart failure // Expert Opin. Investig. Drugs. 2005. 14. (5). 557–566.
8. Honold J., Lehmann R., Heeschen C. et al. Effects of granulocyte colony stimulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease // Arterioscler. Thromb. Vasc. Biol. 2006. (26). 2238–2243.
9. Kang H.J., Kim M.K., Lee H.Y. et al. Five-year results of intracoronary infusion of the mobilized peripheral blood stem cells by granulocyte colony-stimulating factor in patients with myocardial infarction // Eur. Heart J. 2012. 33. (24). 3062–3069.
10. Kastrup J., Ripa R.S., Wang Y. et al. Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical stem cell therapy // Eur. Heart J. 2006. (27). 2748–2754.
11. Kaur K., Sharma A., Singal P. Significance of changes in TNF-α and IL-10 levels in the progression of heart failure subsequent to myocardial infarction // Am. J. Physiol. Heart Circ. Physiol. 2006. (291). 106–113.
12. Kinnaird T., Stabile E., Burnett M.S. et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms // Circ. Res. 2004. (94). 678–685.
13. Krishnamurthy P., Thal M., Verma S. et al. Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium // Circ. Res. 2011. 109. (11). 1280–1289.
14. Krishnamurthy P., Rajasingh J., Lambers E. et al. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT-3 and suppression of HuR // Circ. Res. 2009. (104). 9–18.
15. Lapidot T., Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells // Exp. Hematol. 2002. (30).973–981.
16. Lopes R., Batista M. Jr, Rosa J. et al. Changes in the production of IL-10 and TNF-alpha in skeletal muscle of rats with heart failure secondary to acute myocardial infarction // Arq. Bras. Cardiol. 2010. 94. (3). 293–300.
17. Povsic T.J., Junge C., Nada A. et al. A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: Design of the RENEW study // Am. Heart J. 2013. 165. (6). 854–861.
18. Rehman J., Li J., Orschell C.M., March K.L. Peripheral blood «endothelial progenitor cells» are derived from monocyte/macrophages and secrete angiogenic growth factors // Circulation. 2003. (107). 1164–1169.
19. Rutella S., Zavala F., Danese S. et al. Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance // J. Immunol. 2005. 175. (11). 7085–7091.
20. Segers V.F., Lee R.T. Stem-cell therapy for cardiac disease // Nature. 2008. 451. (7181). 937–942.
21. Tziakas D., Chalikias G., Parissis J.T. et al. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3 // Eur. Cytokine Netw. 2004. (15). 231–239.
About Authors (Correspondence):
Poveshchenko O.V. – candidate of medical sciences, head of the laboratory of lymphotropic therapy and lymphodiagnostic, e-mail: poveschenkoov@yandex.ru
Kim I.I. – researcher of laboratory of lymphotropic therapy and lymphodiagnostic, e-mail: kii5@yandex.ru
Shevchenko A.V. – candidate of biologic sciences, senior researcher of laboratory for clinical immunogenetics, e-mail: shalla64@mail.ru
Pokushalov E.A. – doctor of medical sciences, vice-director, e-mail: cpsc@nricp.ru
Romanov A.B. – candidate of medical sciences, surgeon of the centre of surgical arrhythmology, e-mail: aromanov1981@rambler.ru
Bondarenko N.A. – postgraduate student of laboratory of lymphotropic therapy and lympho diagnostic, e-mail: bond802888@yandex.ru
Lykov A.P. – candidate of medical sciences, leading researcher of laboratory of lymphotropic therapy and lympho diagnostic, e-mail: lykovalex@freemail.ru
Poveshchenko A.F. – doctor of medical sciences, head of the laboratory of physiology of the protective system, e-mail: poveshchenkoa200@mail.ru
Karaskov А.М. – academician of RAS, doctor of medical sciences, director
Konenkov V.I. – academician of RAS, doctor of medical sciences, director, e-mail: lymphology@soramn.ru
